About Elevance Health Inc.
https://www.elevancehealth.comElevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
CEO
Gail Koziara Boudreaux
Compensation Summary
(Year 2005)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-06-01 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 326
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:23M
Value:$8.57B
BLACKROCK INC.
Shares:20.7M
Value:$7.72B
BLACKROCK, INC.
Shares:20.53M
Value:$7.66B
Summary
Showing Top 3 of 1,993
About Elevance Health Inc.
https://www.elevancehealth.comElevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $50.71B ▲ | $5.43B ▼ | $1.19B ▼ | 2.34% ▼ | $5.32 ▼ | $2.14B ▼ |
| Q2-2025 | $49.78B ▲ | $47.48B ▲ | $1.74B ▼ | 3.5% ▼ | $7.72 ▼ | $3.01B ▼ |
| Q1-2025 | $48.89B ▲ | $46.09B ▲ | $2.18B ▲ | 4.47% ▲ | $9.64 ▲ | $3.51B ▲ |
| Q4-2024 | $45.44B ▲ | $44.84B ▲ | $418M ▼ | 0.92% ▼ | $1.84 ▼ | $1.34B ▼ |
| Q3-2024 | $45.15B | $43.77B | $1.02B | 2.25% | $4.36 | $2B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $35B ▲ | $122.75B ▲ | $78.67B ▲ | $43.95B ▲ |
| Q2-2025 | $33.86B ▲ | $121.94B ▲ | $78.09B ▲ | $43.72B ▲ |
| Q1-2025 | $32.94B ▼ | $119.72B ▲ | $77.1B ▲ | $42.5B ▲ |
| Q4-2024 | $33.49B ▼ | $116.89B ▲ | $75.46B ▲ | $41.31B ▼ |
| Q3-2024 | $36.82B | $116.53B | $72.65B | $43.77B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $656M ▼ | $1.14B ▼ | $-1.22B ▼ | $243M ▲ | $153M ▼ | $775M ▼ |
| Q2-2025 | $1.74B ▼ | $2.05B ▲ | $-687M ▼ | $-308M ▲ | $1.06B ▲ | $1.79B ▲ |
| Q1-2025 | $2.18B ▲ | $1.02B ▲ | $103M ▲ | $-1.91B ▼ | $-788M ▼ | $821M ▲ |
| Q4-2024 | $413M ▼ | $706M ▼ | $-1.64B ▼ | $1.41B ▲ | $422M ▼ | $384M ▼ |
| Q3-2024 | $1.01B | $2.68B | $-401M | $-915M | $1.37B | $2.35B |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Carelon Services Segment | $0 ▲ | $16.65Bn ▲ | $18.08Bn ▲ | $18.32Bn ▲ |
 Health Benefits Segment | $37.58Bn ▲ | $41.43Bn ▲ | $41.58Bn ▲ | $42.25Bn ▲ |
CEO
Gail Koziara Boudreaux
Compensation Summary
(Year 2005)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-06-01 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 326
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:23M
Value:$8.57B
BLACKROCK INC.
Shares:20.7M
Value:$7.72B
BLACKROCK, INC.
Shares:20.53M
Value:$7.66B
Summary
Showing Top 3 of 1,993